Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer

Featuring an interview with Professor Giuseppe Curigliano, including the following topics: Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future (0:00) Optimal treatment of HER2-positive mBC with brain metastases (7:42) Screening for and management of T-DXd-related interstitial lung disease (17:32) Gastric toxicities associated with the tucatinib/trastuzumab/capecitabine regimen and with T-DXd; differences in the toxicity profiles of these therapies between patients with HER2-positive and HER2-low breast cancer (23:50) Approach to endocrine therapy for triple-positive disease; emerging data with the AKT inhibitor capivasertib (28:43) Case: A woman in her mid 40s with a family history of breast cancer and upper limb soft tissue sarcoma who presents with a right breast lump and axillary adenopathy on self-examination (35:44) CME information and select publications

Om Podcasten

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.